This observational study is looking at how well a special type of MRI, called Cardiovascular Magnetic Resonance (CMR), can find heart problems in people with sarcoidosis. Sarcoidosis is a disease that can affect many organs, and sometimes it affects the heart without being noticed. The study wants to see if CMR can detect these heart issues better than standard check-ups. You might be able to join if you are 18 or older, have sarcoidosis confirmed by a biopsy, and your doctor suspects you might have sarcoidosis affecting your heart. The study aims to determine if using CMR can help reduce deaths from heart problems, irregular heartbeats (arrhythmic death), or lung problems (pulmonary mortality) in people with sarcoidosis. The study status is currently unclear, and it plans to include 27,000 participants.

Study design

This is an observational study with a planned enrollment of 27,000 participants. It is not a randomized trial, meaning participants will not be assigned to different treatment groups.

What's involved

Patients will undergo Cardiovascular Magnetic Resonance (CMR) in addition to their routine clinical evaluation.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for cardiac mortality, arrhythmic death, and pulmonary mortality for more than 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.